Publications
- FCM marker importance for MRD assessment in T-cell acute lymphoblastic leukemia: An AIEOP-BFM-ALL-FLOW study group report2024 | Second Faculty of Medicine
- CD371+ pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment2024 | Second Faculty of Medicine
- B cell phenotype and serum levels of interferons, BAFF, and APRIL in multisystem inflammatory syndrome in children associated with COVID-19 (MIS-C)2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL2023 | Second Faculty of Medicine
- TLR8/TLR7 dysregulation due to a novel TLR8 mutation causes severe autoimmune hemolytic anemia and autoinflammation in identical twins2022 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Mathematics and Physics
- Early-onset pulmonary and cutaneous vasculitis driven by constitutively active SRC-family kinase HCK2022 | Second Faculty of Medicine
- Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high-risk first relapse B-cell precursor acute lymphoblastic leukemia2022 | Second Faculty of Medicine
- CD38: A target in relapsed/refractory acute lymphoblastic leukemia-Limitations in treatment and diagnostics2022 | Second Faculty of Medicine
- Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining2021 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch2021 | Second Faculty of Medicine
Loading network view...